Prof. Dr. med. Clemens Wendtner
hematology, oncology, infectious disease and palliative medicine
hematology, oncology, infectious disease and palliative medicine
Overview
Country, City
Germany, Munich
Health facility
Academic Hospital Schwabing Munich
Medical unit
Department of hematology, oncology, immunology and palliative care
About the doctor
Skills & Expertise
leukemia
chronic lymphocytic leukemia
lymphocytic leukemia
fludarabine
rituximab
cyclophosphamide
venetoclax
obinutuzumab
bendamustine
tumor
chemoimmunotherapy
ibrutinib
lymphoma
covid19
alemtuzumab
bcell
chemotherapy
lenalidomide
sarcomas
recombinant adenoassociated virus
hyperthermia
oncology
cancer
hematology
infection
coronavirus
chlorambucil
idelalisib
regional hyperthermia
melanoma
neoadjuvant chemotherapy
virological
gene therapy
east respiratory syndrome
vaccination
tumor vaccines
nonhodgkins lymphoma
myeloid leukemia
palliative medicine
hairy cell leukemia
severe infections
malignant
dasatinib
oncogene
lymphocytes
stem cell transplantation
lymphocytic lymphoma
softtissue sarcoma
lymph node
infectious disease
Resume
CV (Curriculum Vitae)
Education
- 1985-1992 Studied medicine at the Westfalische Wilhelms-University in Munster, Germany
- Stayed abroad at Emory University in Atlanta, USA, and the University of Gainesville, USA
- 1989-1990 Academic year abroad in the laboratory of Takis Papas as part of the Biomedical Sciences Exchange Program of the German Academic Exchange Service at the National Cancer Institute of the National Institutes of Health in Bethesda, USA
- 1988 Passed the American Foreign Medical Graduate Examination in the Medical Sciences in Basic Sciences
- 1991 Passed the American Foreign Medical Graduate Examination in the Clinical Sciences
- 1992 German state examination
- 1993 Received medical license
- 1993 Doctorate at the University of Munster, Germany
- 1999 Specialist in internal medicine
- 2000 Specialist in hematology and oncology
- 2002 Habilitation in internal medicine on the importance of recombinant Ebstein-Barr virus vectors and adeno-associated virus vectors for the gene transfer of costimulatory molecules in chronic lymphocytic leukemia
- 2007 Additional qualifications in palliative medicine
- 2011 Additional qualification in haemostaseology
Experience
- 1992 Internship at the medical clinic in the city center of the Ludwig-Maximilians-University Munich, Germany
- 1994-1995 Postdoctorate at the Max Planck Institute for Biochemistry / Gene Center of the Ludwig-Maximilians-University in Munich and the National Heart, Lung, and Blood Institute of the National Institutes of Health in Bethesda, USA
- 1996-2003 Internist with further specialization as a hematologist and internal oncologist at the Medical Clinic in the city center and the Clinic in Groshadern at the Ludwig-Maximilians-University, Germany
- 2004 Senior physician, Clinic I for Internal Medicine, the University of Cologne, Germany
- 2004 Professor (C3) of internal medicine at the University of Cologne, Germany
- 2011 Examiner for the Department of Internal Medicine and Hematology, Internal Oncology at the Bavarian State Medical Association
- 2015 Honorary expert for the benefit assessment of medicinal products at the Federal Joint Committee in Berlin, Germany
- 2017 Member of the ethics committee of the medical faculty of the Ludwig-Maximilians-University Munich, Germany
- 2019 Deputy Head of the Academic teaching hospital of the Ludwig-Maximilians-University, Germany
- 2019 Head of the Department of infectiology, hematology and oncology, Academic Hospital Schwabing Munich, Germany
Awards & Memberships
- 1986-1992 Cusanuswerk study grant
- 1996-2003 Head of a scientific working group in the field of gene therapy for hematological neoplasms at the Research Center for Environment and Health
- 1996-2003 Head of Helmholtz Association of German Research Centers
- 1997 German Patent "Transduction system and its use"
- 1999 Wolfgang Wilmanns Foundation Prize, 5th International Symposium Biological Therapy of Cancer, Munich
- 2000 Young Investigator Award, Connective Tissue Oncology Society, Amsterdam
- 2001 United States Patent “Recombinant AAV vector-based transduction system and use of same”
- 2002 1st prize, 6th International Symposium Biological Therapy of Cancer, Munich
- 2002 United States Patent “Recombinant AAV vector-based transduction system and use of same”
- 2002 Curt-Bohnewand-Prize
- 2004 Member of the Strategy Commission of the German CLL Study Group
- 2006 Member of the Scientific Secretary of this international Study Group
- 2022 Bavarian Order of Merit
Languages
English
German
Publications
S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED CLL12 TRIAL
August, 2023
A PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX COMPARED TO OBINUTUZUMAB AND VENETOCLAX IN PATIENTS WITH HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA
June, 2023
IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL
June, 2023
Location
Kölner Pl., 1, 80804 Munich, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Clemens Wendtner?
The primary specialization of the doctor is hematology, oncology, infectious disease and palliative medicine.
What is the experience of the specialist?
Prof. Dr. med. Clemens Wendtner has been practicing for more than 32 years.
Prof. Dr. med. Clemens Wendtner
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Clemens Wendtner